Pharmaceutical manufacturer Pfizer has announced that it will begin using its west Dublin facility as part of its supply chain for its Covid-19 vaccine.

The company will begin making a component of the vaccine at its Grange Castle site by the end of the year.

This will be an mRNA substance to aid the manufacture outside of Ireland.

The move will involve a $40m investment by Pfizer in its Dublin site and 75 new jobs.

It made the announcement today, saying since Pfizer and BioNTech started distributing their Covid-19 vaccine in December 2020 the companies have made several enhancements to the vaccine's supply chain.

"These enhancements include expanding their existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world to produce the vaccine."

In a statement, it said: "As such, Pfizer is now bringing on additional European-based facility to be a part of the global Pfizer-BioNTech Covid-19 vaccine supply chain network and Grange Castle (Ireland) will contribute to the worldwide supply of the vaccine.

"Pfizer's Grange Castle facility will produce mRNA drug substance. Given the extensive technical transfer process, on-site development, equipment installation and regulatory approvals needed for the sites, we expect both facilities will be brought onto the network by the end of 2021."

Latest coronavirus stories

The news was first reported by The Currency news site last night and was confirmed in a statement from Pfizer today.

The company's Vice President for Global Supply, Dr Paul Duffy, said: "This is a very significant moment for Ireland and for our Grange Castle site. We are immensely proud to be able to play a part in manufacturing Pfizer's Covid-19 vaccine."

IDA Ireland CEO Martin Shanahan said it underlines the importance of the pharma sector in Ireland and demonstrates the capability of the biological sector here.

"This is most welcome news and a strong vote of confidence in the skills, expertise and capability to manufacture this mRNA drug substance substance here," he said.

"This is great news for the Pfizer Grangecastle operation and indeed for the entire Irish biopharma industry as it exemplifies the capability that has been developed here in the country," said Biopharmachem Ireland Director, Matt Moran.

"BPCI is immensely proud of this achievement and the continued and ongoing role that Pfizer and the biopharmaceutical industry plays in helping to end the pandemic."

We need your consent to load this rte-player contentWe use rte-player to manage extra content that can set cookies on your device and collect data about your activity. Please review their details and accept them to load the content.Manage Preferences